Aerie pharmaceuticals, inc. (AERI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-200,759

-199,581

-195,975

-231,961

-239,821

-232,569

-239,624

-186,608

-160,017

-145,105

-115,914

-107,356

-102,142

-99,059

-90,114

-84,261

-79,828

-74,363

-70,487

-65,673

-58,701

-48,133

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation

6,127

5,100

4,280

3,378

2,477

2,400

2,214

1,881

1,596

1,400

1,184

1,113

1,038

970

852

649

451

252

125

102

82

73

0

0

0

Amortization and accretion

17,456

12,976

7,148

6,497

3,773

1,646

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and fees

-

-

-

-

-

-

-

-

-

-

306

305

304

303

300

301

303

305

309

232

154

77

0

0

0

Amortization and accretion of premium or discount on investments, net

-

-

-

-

-

-

-

-

-

-

-174

-310

-430

-525

-534

-540

-554

-570

-608

-564

-523

-416

0

0

0

Stock-based compensation

43,002

45,093

43,634

43,006

42,629

38,728

37,021

33,600

29,947

26,078

23,352

20,894

18,110

16,794

14,926

14,143

13,738

12,945

12,015

11,091

9,997

9,178

0

0

0

Other non-cash

124

271

315

260

606

270

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized foreign exchange (gain) loss

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities
Accounts receivable, net

28,183

35,639

31,317

24,526

14,758

2,715

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

9,242

10,257

8,470

4,157

8,687

9,689

5,299

5,546

969

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid, current and other assets

3,163

2,144

4,461

5,801

554

791

3,002

2,566

5,294

2,239

-782

878

928

1,852

1,518

-24

132

840

935

498

895

717

0

0

0

Accounts payable, accrued expenses and other current liabilities

26,081

28,766

34,235

32,146

32,189

26,583

13,830

9,953

-185

925

3,685

-547

-2,154

2,479

-209

2,608

3,111

5,385

4,969

3,244

5,765

4,829

0

0

0

Operating lease liabilities

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

0

0

0

-

-

0

0

Net cash used in operating activities

-143,613

-150,430

-154,820

-159,886

-160,380

-152,576

-147,212

-125,226

-109,194

-93,213

-85,909

-85,794

-85,336

-79,840

-75,229

-65,990

-61,797

-55,746

-52,845

-50,393

-42,536

-33,726

0

0

0

Cash flows from investing activities
Purchase of available-for-sale investments

181,288

165,454

97,268

0

0

56,195

59,468

106,258

115,124

104,490

116,438

70,368

67,465

35,169

40,260

52,125

51,949

46,872

87,343

77,499

74,219

95,376

0

0

0

Proceeds from sales and maturities of investments

50,557

0

1,000

15,470

84,522

108,297

146,754

156,179

99,068

88,153

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Maturity of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56,993

-

50,892

41,842

35,567

20,739

0

0

0

Purchase of property, plant and equipment

6,259

9,958

9,820

15,399

27,126

31,313

38,301

36,408

24,192

15,970

10,758

7,212

5,646

5,077

2,817

2,687

3,076

3,280

1,890

1,174

691

181

0

0

0

Net cash provided by (used in) investing activities

-144,825

-183,247

-106,088

71

57,396

20,789

38,485

3,013

-50,748

-42,807

-55,509

-19,248

-17,941

18,100

9,000

5,200

5,717

9,382

-36,342

-35,082

-37,843

-73,318

0

0

0

Cash flows from financing activities
Proceeds from Issuance of Common Stock

-

-

-

-

-

135,972

148,141

148,141

270,187

134,215

0

0

0

-

-

-

-

50,451

47,100

35,426

35,000

0

0

0

0

Payments related to issuance of stock for stock-based compensation arrangements, net

-139

684

100

969

4,451

3,630

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,286

-

0

0

0

-

-

-

-

Proceeds from exercise of stock purchase rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

96

124

124

119

0

0

0

Tax withholdings related to restricted stock awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

-

0

0

0

-

-

-

-

Proceeds from exercise of warrants

386

761

375

375

375

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds related to issuance of stock for stock-based compensation arrangements, net

-

-

-

-

-

-

-

-

-

1,429

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other financing

-188

-336

-484

-535

-592

-683

-535

-387

-239

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

273,749

274,799

274,656

-1,470

2,351

137,036

149,603

150,211

269,909

135,644

123,558

289,173

168,545

168,625

171,221

18,393

16,896

51,838

47,249

158,515

157,986

122,981

0

0

0

Net change in cash and cash equivalents

-14,689

-58,878

13,748

-161,285

-100,633

5,249

40,876

27,998

109,967

-376

-17,860

184,131

65,268

106,885

104,992

-42,397

-39,184

5,474

-41,938

73,040

77,607

15,937

0

0

0

Supplemental disclosures
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

2,192

2,192

2,192

2,186

2,186

1,635

1,090

551

0

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

1,790

1,790

1,920

2,389

600

0

0

0

-

-

-

-

Non-cash investing and financing activities
Build-to-suit lease transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Interest capitalized during construction period for build-to-suit lease transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment

-583

771

1,849

-725

-6,279

3,526

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-